Mistaken approval of Alzheimer’s Drug

Aducanumab is not just a drug that doesn’t seem to work, but it is an enormously expensive drug but provides false hope to desperate families.

An examination of medical ethics and the practitioners who define them. Sign up to receive the Second Opinion topics in newsletter form at kcrw.com/newsletters .